Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma

Arnaud Bourdin (1, 2) , Nicolas Molinari (3)

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
3 IMAG - Institut Montpelliérain Alexander Grothendieck

Mots clés: Benralizumab; Indirect treatment comparison; Matching-adjusted indirect comparison; Mepolizumab; Severe eosinophilic asthma; Dupilumab

Domaines: Allergologie; Pneumologie et système respiratoire; Immunothérapie; Méthodologie [stat.ME]

Arnaud Bourdin, Nicolas Molinari. Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma. Respiratory Medicine, 2022, 191, pp.105999. ⟨10.1016/j.rmed.2020.105999⟩. ⟨hal-03548301⟩